Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Public ClinicalTrials.gov record NCT05766813. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a diagnosis of Parkinson's Disease consistent with the UK Parkinson's Disease Society (UKPDS) Brain Bank diagnostic criteria, who are experiencing wearing off symptoms and levodopa-induced dyskinesia.
Study identification
- NCT ID
- NCT05766813
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2023 (Actual)
- Primary completion
- Oct 28, 2025 (Actual)
- Completion
- Nov 4, 2025 (Actual)
- Last update posted
- Jul 24, 2026
2023 – 2025
United States locations
- U.S. sites
- 35
- U.S. states
- 15
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Phoenix | Arizona | 85013 | — |
| Clinical Site | Scottsdale | Arizona | 85251 | — |
| Clinical Site | Irvine | California | 92697 | — |
| Clinical Site | Loma Linda | California | 92354 | — |
| Clinical Site | Altamonte Springs | Florida | 32714 | — |
| Clinical Site | Boca Raton | Florida | 33486 | — |
| Clinical Site | Coral Springs | Florida | 33067 | — |
| Clinical Site | Doral | Florida | 33178 | — |
| Clinical Site | Hallandale | Florida | 33009 | — |
| Clinical Site | Maitland | Florida | 32751 | — |
| Clinical Site | Miami | Florida | 33136 | — |
| Clinical Site | Ocala | Florida | 34470 | — |
| Clinical Site | Orlando | Florida | 32804 | — |
| Clinical Site | Orlando | Florida | 32825 | — |
| Clinical Site | Port Orange | Florida | 32127 | — |
| Clinical Site | Tampa | Florida | 33612 | — |
| Clinical Site | Augusta | Georgia | 30912 | — |
| Clinical Site | Decatur | Georgia | 30030 | — |
| Clinical Site | Kansas City | Kansas | 66160 | — |
| Clinical Site | Farmington Hills | Michigan | 48334 | — |
| Clinical Site | Golden Valley | Minnesota | 55427 | — |
| Clinical Site | Albany | New York | 12208 | — |
| Clinical Site | Rock Hill | South Carolina | 29732 | — |
| Clinical Site | Franklin | Tennessee | 37067 | — |
| Clinical Site | Memphis | Tennessee | 38157 | — |
| Clinical Site | Austin | Texas | 78746 | — |
| Clinical Site | Dallas | Texas | 75243 | — |
| Clinical Site | Georgetown | Texas | 78628 | — |
| Clinical Site | Alexandria | Virginia | 22311 | — |
| Clinical Site | Falls Church | Virginia | 22042 | — |
| Clinical Site | Henrico | Virginia | 23233 | — |
| Clinical Site | Kirkland | Washington | 98034 | — |
| Clinical Site | Spokane | Washington | 99202 | — |
| Clinical Site | Crab Orchard | West Virginia | 25827 | — |
| Clinical Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05766813, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05766813 live on ClinicalTrials.gov.